Pharma Reviews: 20 companies lost over Rs 2-lakh crore market-cap in first half of 2017

“Indian pharma companies have seen a significant correction / multiple de-rating due to an uncertain regulatory environment and pricing pressure (on ...
Read more: 20 companies lost over Rs 2-lakh crore market-cap in first half of 2017